Zeno Pathology obtained IVD CE-mark
zeno pathology

WSK Medical, a company developing Artificial Intelligence (AI) solutions for (early) cancer detection, has received the IVD CE mark for their AI digital pathology solution called Zeno Pathology.

Zeno Pathology considerably reduces observer variability and manual analysis time whilst increasing the speed, consistency, and accuracy to analyse H&E and IHC stained breast cancer whole slide images. Zeno Pathology has the flexibility of being integrated in the existing digital workflow and is co-developed with the Computational Pathology lab at the Netherlands Cancer Institute.

If you want more information about Zeno Pathology, please contact us.

Related posts

Zeno AI Nominated National Healthcare Innovation Award 2023

Zeno AI Nominated National Healthcare Innovation Award 2023

Zeno AI - the first of its kind real-time AI solution for early laryngeal (throat) cancer detection for ENT-surgeons - is nominated for the regional preliminaries of the National Healthcare Innovation Award and will pitch Zeno AI in front of a jury in Amsterdam on...

read more